Search Results

The Smart Reactors Camouflage Coated Extracorporeal Cardiopulmonary Circuit Tubing Set is indicated for use in the extracorporeal circuit during cardiopulmonary bypass (CPB) surgical procedures for ≤ 6 hours.

The Smart Reactors Camouflage Coated Extracorporeal Cardiopulmonary Tubing is a tubing pack intended for use during cardiopulmonary bypass. The tubing is DOP free polyvinylchloride (PVC) with an inner diameter of 9.5mm coated with Smart Reactors' proprietary Camouflage coating provided in a length of 180cm.

This device is intended for use in the adult patient population.

N/A

Ask a specific question about this device

These cannulae are indicated for CPB procedures requiring delivery of cardioplegia in a retrograde direction through the coronary sinus for up to 6 hours in duration.

The Retrograde Coronary Sinus Perfusion Cannulae models in scope of this 510(k) consist of a wire-wound silicone cannula body with a beveled tip (6-Fr models have a non-wire wound cannula body). Two side holes are present near the tip. The back of the cannula body terminates in a locking female luer. A pressure monitoring line is an integral part of the cannula body, beginning at the tip and terminating in a locking female luer fitting or 3-way stopcock with a locking female luer fitting. An inflatable balloon is located at the distal beveled tip. The inflation assembly is located at the back of the cannula body and contains a female slip luer and a one-way valve assembly. Cannulae have a guidewire or solid stylet with a male luer handle or a TruTouch handle.

N/A

Ask a specific question about this device

The Dual Stage Venous Return Cannula is indicated for single tube venous drainage from the right atrium and vena cava during cardiopulmonary bypass surgery for up to six hours.

Dual Stage Venous Return Cannulae are single-use, non-toxic, non-pyrogenic fluid path devices and supplied sterile and individually packaged.

The devices are composed of the cannula: an open lumen PVC polymer tube incorporating wire reinforcement in distal section. In some models is present a malleable obturator inserted into the cannula to allow the placement of the cannula along the vein. Once the cannula is positioned onto the vessel the surgeon removes the obturator from the cannula tubing and connects it to the venous line.

The distal end of the cannula has a lighthouse-shaped tip, allowing the venous blood to flow from the vessel into the cannula, in addition the distal sections of the cannula are perforated with multiple holes at multiple stages to better allow the fluid flows from outside into the cannula body. The clear proximal section is not reinforced to allow clamping; the proximal end typically does not have any pre-mounted connector and can accommodate a barbed connector for standard cardiopulmonary bypass tubing (½" diameter). In some models a pre-mounted 1/2" barbed connector is present.

The following cannula models are available:

The Dual Stage Venous Return Cannulae are the modified version of the disposables currently marketed under K943934.

Both modified and unmodified cannulae models are recommended for use as Venous cannula during cardiopulmonary bypass up to six hours.

N/A

Ask a specific question about this device

The device is indicated for temporary use during the creation of anastomosis for medical conditions requiring beating heart coronary artery bypass procedures.

The disposable intracoronary shunts consist of a flexible tube. Both ends of the tube feature a teardrop shaped tip made from radiopaque material with 14 mm between the ends. Tip diameters range from 1.00 mm to 3.00 mm. A tether with a tag made of radiopaque material is permanently attached to the shunts. These devices are sterile, nonpyrogenic, disposable and intended for single use only. They are sterilized using ethylene oxide and are categorized as external communicating devices, with limited contact (<=24 hours) circulating blood contact.

N/A

Ask a specific question about this device

The AngioVac Cannula is indicated for use as a venous drainage cannula and for removal of fresh, soft thrombi or emboli during extracorporeal bypass for up to 6 hours.

The AngioVac Cannula is a venovenous cannula with a nitinol basket reinforced, self-expandable funnel shaped distal tip collapsed using an over-sheath that can be advanced through a 26 Fr sheath and over a guidewire into the venous system percutaneously or via a surgical cut-down. During use, the cannula is connected to an extracorporeal circuit, an AngioVac Circuit, a commercially available centrifugal pump and bubble trap. A commercially available reinfusion cannula is placed for venous return (typically within internal jugular or one of the common femoral veins) and connected to the extracorporeal circuit. The funnel tip is actuated by advancing the AngioVac Cannula out of the sheath deploying the self-expanding nitinol reinforced funnel shaped tip at the desired tip angle. Once optimal flow rate is achieved, the AngioVac Cannula is advanced under image guidance towards the undesirable intravascular (i.e. thrombus or emboli) until it is engaged, suctioned into the cannula and removed from the vasculature. The blood is then circulated though the filter and returned to the patient via the venous return cannula. A benefit of the AngioVac Cannula is that it allows for removal of thrombus and embolic material, while minimizing blood loss via recirculation of blood through a standard extracorporeal (venovenous) bypass circuit. Target vessels for the thrombus/embolus extraction include but are not limited to, the iliofemoral vein, Inferior Vena Cava (IVC), Superior Vena Cava (SVC) and Right Atrium (RA). The device is provided in ~20° (AngioVac C20) and ~180° (AngioVac C180) angled configurations.

N/A

Ask a specific question about this device

The Remote Access Perfusion (RAP) femoral venous cannula is intended for use as a venous drainage cannula during cardiopulmonary bypass up to six hours

RAP Femoral venous cannulae are single-use, non-toxic, non-pyrogenic fluid path devices and supplied sterile and individually packaged.

The device is composed of a cannula and a malleable obturator inserted into the cannula to allow the placement of the cannula along the femoral vein till the vena cava. The cannula and the obturator are packaged within the same pouch and sold together.

The cannula is an open lumen PVC polymer tube incorporating wire reinforcement in distal sections. The distal sections of the cannula are perforated with multiple holes at multiple stages to allow fluid flow. The clear proximal section is not reinforced to allow clamping; the proximal end terminates in a 3/8" to ½" barbed connector for standard cardiopulmonary bypass tubing.

The RAP femoral arterial cannulae are the modified version of the disposables currently marketed as the RAP Femoral Venous cannula (K052081).

This document, an FDA 510(k) Clearance Letter, is for a medical device (a cannula) and not for a software or AI-based medical device. Therefore, it does not contain the information requested in the prompt regarding acceptance criteria and studies that prove a device meets acceptance criteria for an AI/software device.

The questions in your prompt are highly specific to AI/Machine Learning device validation, such as:

1. Acceptance criteria for AI performance: (e.g., sensitivity, specificity, AUC)
2. Sample size, provenance, expert ground truth, adjudication: These are standard for evaluating AI model performance.
3. MRMC study and effect size: How AI assists human readers.
4. Standalone performance: Algorithm without human input.
5. Type of ground truth: Pathology, outcomes, expert consensus.
6. Training set details: Sample size and ground truth establishment.

None of this information is relevant or present in the provided 510(k) clearance letter for the RAP Femoral Arterial Cannulae, which is a physical device subject to mechanical, material, and biocompatibility testing.

The document confirms the device meets acceptance criteria through:

• Non-Clinical Performance Data: Extensive verification and validation testing of the physical device components and function (e.g., visual inspection, connector testing, flow rate, kink test, pull strength, blood trauma characterization, biocompatibility tests).
• No Clinical Performance Data: The submission explicitly states "No clinical testing was conducted in support of the RAP Femoral venous cannulae, as the indications for use and technical characteristics are equivalent to those of the predicate devices, which have been on the market for several years with proven safety and efficacy of use."

Therefore, I cannot extract the information asked in your prompt from this particular document.

Ask a specific question about this device

The EasyFlow Aortic Cannula is intended for use in the perfusion of the aorta during cardiovascular surgery procedures requiring extracorporeal cardiopulmonary bypass for up to 6 hours.

The EasyFlow Duo Cannula with guidewire is intended for use with cardiopulmonary bypass as an arterial return femoral cannula for up to 6 hours.

Easyflow & Easyflow Duo are single-use, non-toxic, non-pyrogenic fluid path devices and supplied sterile and individually packaged.

The Easyflow & Easyflow Duo are composed of the cannula and a malleable obturator inserted into the cannula to allow the placement of the cannula along the Artery.

The cannula is an open lumen PVC polymer tube incorporating wire reinforcement in distal sections. The distal sections of the cannula are perforated with multiple holes at multiple stages to allow fluid flow. The clear proximal section is not reinforced to allow clamping; the proximal end terminates in a 3/8" barbed connector for standard cardiopulmonary bypass tubing

In the Easyflow Duo models the device has a 0.035" hole punched in the very distal tip of the cannula and the obturator has an approx. 0.035" internal diameter central lumen to accommodate a 0.035" guide wire used to drive the cannula along the vessel till its final placement. Once the cannula is positioned onto the vessel the surgeon removes the obturator from the cannula tubing and connects it to the arterial line.

The Easyflow is packaged as sterile stand-alone device while the Easyflow Duo is packaged into a tray containing also a Guidewire, a Needle and Vascular Dilators in order to have a kit for vascular access packaged together with the cannula.

The Easyflow & Easyflow Duo are the modified version of the disposables currently marketed as the Easyflow cannula (K060101) and the Easyflow Duo cannula (K091542). Both modified and unmodified cannulae models are recommended for use as an arterial return cannula during cardiopulmonary bypass up to six hours

The provided FDA 510(k) Clearance Letter for the Easyflow Cannulae does not contain any information related to a study proving the device meets acceptance criteria for an AI/ML (Artificial Intelligence/Machine Learning) powered medical device.

This document describes a medical device (cannulae for cardiopulmonary bypass) which is a physical, single-use, non-toxic, non-pyrogenic fluid path device. The clearance is based on "substantial equivalence" to predicate devices, meaning it has similar indications for use and technological characteristics, with the primary change being the removal of phthalates (DEHP and DnHP) from the PVC materials.

Therefore, I cannot fulfill your request to describe the acceptance criteria and the study that proves the device meets the acceptance criteria in the context of an AI/ML device, as this information is not present in the provided text.

The information you asked for, such as sample size, data provenance, number of experts, adjudication methods, MRMC studies, standalone performance, ground truth types, and training set details, are all highly specific to the validation of AI/ML algorithms, which are not relevant to the Easyflow Cannulae as described in this FDA clearance.

In summary, based on the provided document, there is no AI/ML component to the Easyflow Cannulae, and thus no such study or acceptance criteria as you've outlined would be applicable or present.

Ask a specific question about this device

This cannula is intended for use in venous drainage via the right atrium and inferior vena cava simultaneously during cardiopulmonary bypass surgery up to six hours or less.

The MC2™ Two-Stage Venous Cannula and MC2X™ Three-Stage Venous Cannula models feature wire wound polyvinyl chloride (PVC) bodies with side ports in the distal tip, a ported atrial basket drainage site located along the length of the cannula body, and a 3/8-inch (0.95 cm) to 1/2-inch (1.27 cm) connection site. The overall length of each cannula body is approximately 15¼ inch (38.7 cm). Insertion depth marks are provided to aid in positioning of the cannula. Each cannula is nonpyrogenic, is intended for single use, and has been sterilized using ethylene oxide.

This document is a 510(k) clearance letter for a medical device: the MC2™ Two-Stage Venous Cannula and MC2X™ Three-Stage Venous Cannula. It does not contain any information about an AI/ML-driven medical device, nor does it discuss acceptance criteria, test sets, ground truth establishment, or human reader studies related to AI performance.

The clearance is for a physical device used in cardiopulmonary bypass surgery, and the summary of performance data refers to pre-clinical bench testing related to material formulation changes, not algorithmic performance.

Therefore, I cannot provide the requested information based on the provided text. The prompt asks for details about AI/ML device performance, which are entirely absent from this 510(k) clearance.

Ask a specific question about this device

The Quantum Perfusion Dual Lumen Cannula is intended for use as a single cannula for both venous drainage and reinfusion of blood via the internal jugular vein during extracorporeal life support procedures for periods of maximum 6 hours.

Quantum Perfusion Dual Lumen Cannula product family are single use devices intended to be used in medical procedures providing cardiac and/or respiratory support up to 6 hours. Devices are characterized by two coaxial catheters and are designed to be coupled with an extracorporeal circuit for artificial oxygenation of the blood and carbon dioxide removal.

Devices exploit a single site insertion which reduces the invasiveness of extracorporeal procedures. It can be inserted via a percutaneous approach through the right internal jugular vein. Blood is drained through the lumen of the outer catheter and returned through the lumen of the inner catheter.

Devices feature multiple inflow openings in the outer catheter limiting the circulation of unoxygenated blood.

Devices are non-toxic, non-pyrogenic, sterilized by ethylene oxide and packaged in a double pouch. All the devices' surfaces in contact with blood are coated with a phosphorylcholine-based biocompatible material.

The provided document is a 510(k) summary for a medical device called the "Quantum Perfusion Dual Lumen Cannula 31F-V1." It does not describe an AI/ML powered device, therefore the requested information regarding acceptance criteria, study details, and human-AI interaction is not applicable. The document focuses on regulatory approval for an updated version of an existing medical cannula.

Here's a breakdown of why this information isn't available in the document:

• Device Type: The device is a physical medical cannula used in cardiopulmonary bypass, not an AI/ML software or algorithm.
• Approval Type: The document is a 510(k) premarket notification, which is for demonstrating substantial equivalence to a legally marketed predicate device, not for a novel AI/ML application that would require extensive performance studies as requested.
• Performance Data: The "Performance Data" section explicitly states "NON-CLINICAL TESTING" and lists updates to labeling and performance tests according to recognized consensus standards for the physical device. It also states "No animal studies have been performed" and "No clinical data have been included."

Therefore, I cannot provide the requested information for acceptance criteria and study proving device meets said criteria as it pertains to AI/ML devices.

Ask a specific question about this device

Cardiopulmonary Bypass (CPB): Bio-Medicus Life Support catheters are peripheral-access catheters used to perfuse vessels or organs in conjunction with extracorporeal cardiopulmonary bypass (CPB) procedures. The catheter introducer is intended to facilitate proper insertion and placement of the appropriately sized catheter within the vessel. Catheter models with tip lengths of 18 cm (7.09 in), 50 cm (19.7 in), or 55 cm (21.7 in) and without additional side holes may be used as either drainage or reinfusion catheters. This product is intended for use in adult and pediatric patients for up to 6 hours.

Extracorporeal Membrane Oxygenation (ECMO) and Extracorporeal Life Support (ECLS): The Bio-Medicus Life Support catheters and introducers are single-lumen drainage or reinfusion peripheral-access catheters to be used in ECMO or ECLS with an extracorporeal circuit intended for use in adult and pediatric patients with acute respiratory or acute cardiopulmonary failure. where other available treatment options have failed, and continued clinical deterioration is expected or the risk of death is imminent.

The Bio-Medicus Life Support™ catheter is a single-lumen catheter used to drain or reinfuse blood. The introducer facilitates proper insertion and placement of the appropriately sized catheter over a guidewire within the vessel. These devices are intended to perfuse vessels or organs in conjunction with extracorporeal support, including cardiopulmonary bypass (CPB), Extracorporeal Membrane Oxygenation (ECMO) and Extracorporeal Life Support (ECLS). Catheter models with tip lengths of 18 cm (7.09 in), 50 cm (19.7 in), or 55 cm (21.7 in), with and without additional side holes may be used as either drainage or reinfusion catheters.

These devices are sterile, nonpyrogenic, disposable, intended for single use only. Do not store the product above 25℃ (77°F).

The provided text is a 510(k) summary for the Medtronic Bio-Medicus Life Support Catheter and Introducer. It details the device, its intended use, comparison to a predicate device, and performance testing. However, it does not describe acceptance criteria for an AI-powered device, nor does it detail a study proving such a device meets acceptance criteria.

The information provided pertains to a traditional medical device (a catheter and introducer) with a material formulation change, and the "performance testing" described is bench testing and biocompatibility assessments to demonstrate substantial equivalence to a predicate device. There is no mention of AI, machine learning, or software performance in terms of diagnostic accuracy or effect on human readers.

Therefore,Based on the provided text, it is not possible to describe the acceptance criteria or a study that proves a device meets acceptance criteria for an AI-powered device. The document pertains to a traditional medical device (catheter and introducer), specifically addressing a material change to a component (luer cap). There is no mention of AI, machine learning, or any form of algorithm-driven performance evaluation.

The "Summary of Performance Testing" section focuses on demonstrating substantial equivalence of the modified luer cap through risk-based testing, functional testing, and biocompatibility assessment, which are standard for physical medical devices.

Here's a breakdown of why the requested information cannot be provided from the given text:

• No AI Component: The device described (Bio-Medicus Life Support Catheter and Introducer) is a physical medical device. The document explicitly states the "device modification was made to the predicate device: Luer cap material formulation change (vented connector models)." This is a hardware change, not a software or AI change.
• No Diagnostic or Classification Task: The device's function is to facilitate extracorporeal support procedures (CPB, ECMO, ECLS), not to interpret data, diagnose conditions, or assist human readers in a diagnostic capacity.
• No Performance Metrics for AI: The "performance testing" described is for the physical integrity and biocompatibility of the luer cap ("functional testing and biocompatibility assessment"), which are not the types of metrics (e.g., sensitivity, specificity, AUC, human reader improvement) that would be used for AI device acceptance criteria.

To directly answer your request based on the provided text, I must state that the information is not present:

1. A table of acceptance criteria and the reported device performance: Not applicable. The document describes bench testing to qualify a material change, not AI performance metrics.
2. Sample sized used for the test set and the data provenance: Not applicable. The "test set" here refers to physical components for bench testing, not a dataset for AI evaluation.
3. Number of experts used to establish the ground truth... and qualifications: Not applicable. Ground truth as typically defined for AI validation (e.g., for image interpretation) is not established for this physical device.
4. Adjudication method: Not applicable. There is no interpretive task requiring adjudication.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done: No. This type of study is for AI-assisted human performance, which is not relevant to this device.
6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done: Not applicable. There is no algorithm.
7. The type of ground truth used: Not applicable.
8. The sample size for the training set: Not applicable. There is no training set for an AI model.
9. How the ground truth for the training set was established: Not applicable.

In conclusion, the provided FDA document is for a traditional medical device (catheter) and does not contain any information related to AI acceptance criteria or AI performance studies.

Ask a specific question about this device